The ESCMID Study Group for Mycobacterial Infections (ESGMYC) is dedicated to fighting mycobacterial infections, including tuberculosis, leprosy, and non-tuberculous mycobacterial infections. Aiming to improve their diagnosis, treatment, and prevention, ESGMYC is committed to:
Clinical standards for the management of adverse effects during treatment for TB.
Singh KP, Carvalho ACC, Centis R, D'Ambrosio L, Migliori GB, Mpagama SG, Nguyen BC, Aarnoutse RE, Aleska A, van Altena R, Bhavani PK, Bolhuis M, Borisov S, ‘t Boveneind-Vrubleuskaya N, Bruchfeld J, Caminero JA, Carvalho I, Cho JG, Davies-Forsman L, Dedicoat M, Dheda K, Dooley K, Furin J, Garcia-Garcia JM, Garcia-Prats A, Hesseling AC, Heysell SK, Hu Y, Kim HY, Manga S, Marais B, Margineanu I, Märtson AG, Munoz M Torrico, Nataprawira HM, Nuntes E, Ong CWM, Otto-Knapp R, Palmero DJ, Peloquin CA, Rendon A, Rossato Silva D, Ruslami R, Saktiawati AMI, Santoso P, Schaaf HS, Seaworth B, Simonsson U, Singla R, Skrahina A, Solovic I, Srivasta SK, Stocker SL, Sturkenboom MG, Svensson EM, Tadolini M, Thomas TA, Tiberi S, Trubiano J, Udwadia ZF, Verhage A, Vu DH, Akkerman OW, Alffenaar JWC, Denholm JT. Int J Tuberc Lung Dis. 2023;27(7):506–519.
Standards for clinical trials for treating TB.
du Cros P, Greig J, Alffenaar J, Cross GB, Cousins C, C Berry, Khan U, Phillips PPJ, Velásquez GE, Furin J, Spigelman M, Denholm J, Thi SS, Tiberi S, Huang GKL, Marks GB, Turkova A, Guglielmetti L, Chew KL, Nguyen HT, Ong CWM, Brigden G, Singh K, Motta I, Lange C, Seddon JA, Nyang’wa BT, Maug AKJ, Gler MT, Dooley KE, Quelapio M, Tsogt B, Menzies D, Cox V, Upton CM, Skrahina A, McKenna L, Horsburgh R, Marais BJ. Int J Tuberc Lung Dis. 2023;27(12):885–898.
Recent advances in the treatment of tuberculosis.
Motta I, Boeree M, Chesov D, Dheda K, Günther G, Horsburgh CR Jr, Kherabi Y, Lange C, Lienhardt C,McIlleron HM, Paton NI, Stagg HR, Thwaites G, Udwadia Z, Van Crevel R, Velásquez GE, Wilkinson RJ, Guglielmetti L; Study group on Mycobacteria (ESGMYC) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Clin Microbiol Infect. 2023;22:S1198-743X(23)00339-7.
Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
Fröberg G, Maurer FP, Chryssanthou E, Fernström L, Benmansour H, Boarbi S, Mengshoel AT, Keller PM, Viveiros M, Machado D, Fitzgibbon MM, Mok S, Werngren J, Cirillo DM,Alcaide F, Hyyryläinen HL, Aubry A, Andres S, Nadarajan D, Svensson E, Turnidge J, Giske CG, Kahlmeter G, Cambau E, van Ingen J, Schön T; EUCAST AMST and ESGMYC study groups. Clin Microbiol Infect. 2023;29(6):758–764.
Joint ESGMYC and NTM-NET webinar: Critical review on recent drug resistant-TB trials and challenges related to implementation of new WHO recommendations
How to use genomic data for optimizing the management of tuberculosis and other mycobacterial infections
Post-graduate course
If you have questions or comments for our study group, we warmly invite you to contact us!